SalivaTech Co., Ltd announced a private placement of 20,000 shares at a price of ¥5,000 per share for gross proceeds of ¥100,000,000 on December 26, 2017. The transaction will include participation from Nissui Pharmaceutical Co., Ltd. (TSE:4550). The investor has signed a contract with the company. The payment date is December 27, 2017.